[1] 中华人民共和国国家卫生健康委员会医政司.原发性肝癌诊疗指南(2024年版).中华肝脏病杂志,2024,32(7):581-630. [2] Jia G, He P, Dai T, et al. Spatial immune scoring system predicts hepatocellular carcinoma recurrence. Nature, 2025, 640(8060): 1031-1041. [3] 杨佳欣, 杨紫郡, 陈卫. 双源CT双能量TNC技术图像质量与诊断肝细胞癌效能分析. 实用肝脏病杂志, 2024, 27(6): 915-918. [4] Zhang X, Chen C, Wang Y, et al. Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation. J Gastroenterol Hepatol, 2024, 39(11): 2272-2280. [5] Qu H, Zhang S, Guo M, et al. Deep learning model for predicting proliferative hepatocellular carcinoma using dynamic contrast-enhanced MRI: implications for early recurrence prediction following radical resection. Acad Radiol, 2024, 31(11): 4445-4455. [6] Wang T, Chen H, Chen Z, et al. Prediction model of early recurrence of multimodal hepatocellular carcinoma with tensor fusion. Phys Med Biol, 2024, 69(12): 125001. [7] Kinoshita M, Ueda D, Matsumoto T, et al. Deep learning model based on contrast-enhanced computed tomography imaging to predict postoperative early recurrence after the curative resection of a solitary hepatocellular carcinoma. Cancers (Basel), 2023, 15(7): 2076. [8] Meng F, Wang J, Zhu X D, et al. Risk factors for recurrence in patients with hepatocellular carcinoma after curative resection or ablation. J Hepatocell Carcinoma, 2025, 12: 2501-2511. [9] Liu Y, Liu X, Xu Q, et al. A prognostic model of colon cancer based on the microenvironment component score via single cell sequencing. In Vivo, 2022, 36(2): 753-763. [10] Miyata T, Matsumoto T, Nakao Y, et al. Major postoperative complications are associated with early recurrence of hepatocellular carcinoma following hepatectomy. Langenbecks Arch Surg, 2022, 407(6): 2373-2380. [11] Pan Y X, Chen J C, Fang A P, et al. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy. Cancer Commun, 2019, 39(1): 55. [12] Lee S K, Lee S W, Jang J W, et al. Immunological markers, prognostic factors and challenges following curative treatments for hepatocellular carcinoma. Int J Mol Sci, 2021, 22(19):10271. [13] Zeng J, Zeng J, Lin K, et al. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection. Hepatobiliary Surg Nutr, 2022, 11(2): 176-187. [14] Li H, Zhang J, Zheng Z, et al. Preoperative histogram analysis of intravoxel incoherent motion (IVIM) for predicting microvascular invasion in patients with single hepatocellular carcinoma. Eur J Radiol, 2018, 105: 65-71. [15] Xu J, Bao G, Chen H, et al. Research on cancer prediction based on feature optimization and multimodal fusion. Health Care Sci, 2025, 4(6): 392-409. [16] Wang H, Chen J, Gao W, et al. Construction of a nomogram with IrAE and clinic character to predict the survival of advanced G/GEJ adenocarcinoma patients undergoing anti-PD-1 treatment. Front Immunol, 2024, 15: 1432281. [17] Wang J, Wu D, Sun M, et al. Deep segmentation feature-based radiomics improves recurrence prediction of hepatocellular carcinoma. BME Front, 2022, 2022: 9793716. [18] Yin Y, Jia S, Zheng J, et al. Deep learning radiomics of left atrial appendage features for predicting atrial fibrillation recurrence. BMC Med Imaging, 2025, 25(1): 186. [19] Yakubov E, Schmid S, Hammer A, et al. Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema. Front Oncol, 2023, 13: 1176038. [20] Sun L Y, Ouyang Q, Cen W J, et al. A model based on artificial intelligence algorithm for monitoring recurrence of HCC after hepatectomy. Am Surg, 2023, 89(5): 1468-1478. |